94 related articles for article (PubMed ID: 30231202)
1. Surface Plasmon Resonance Sensing on Naturally Derived Membranes: A Remyelination-Promoting Human Antibody Binds Myelin with Extraordinary Affinity.
Vala M; Jordan LR; Warrington AE; Maher LJ; Rodriguez M; Wittenberg NJ; Oh SH
Anal Chem; 2018 Nov; 90(21):12567-12573. PubMed ID: 30231202
[TBL] [Abstract][Full Text] [Related]
2. rHIgM22 enhances remyelination in the brain of the cuprizone mouse model of demyelination.
Mullin AP; Cui C; Wang Y; Wang J; Troy E; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Neurobiol Dis; 2017 Sep; 105():142-155. PubMed ID: 28576706
[TBL] [Abstract][Full Text] [Related]
3. A recombinant human IgM promotes myelin repair after a single, very low dose.
Warrington AE; Bieber AJ; Ciric B; Pease LR; Van Keulen V; Rodriguez M
J Neurosci Res; 2007 Apr; 85(5):967-76. PubMed ID: 17304578
[TBL] [Abstract][Full Text] [Related]
4. Method of identifying natural antibodies for remyelination.
Warrington AE; Rodriguez M
J Clin Immunol; 2010 May; 30 Suppl 1(0 1):S50-5. PubMed ID: 20387101
[TBL] [Abstract][Full Text] [Related]
5. Identification of the Lipid Antigens Recognized by rHIgM22, a Remyelination-Promoting Antibody.
Grassi S; Cabitta L; Prioni S; Mauri L; Ciampa MG; Yokoyama N; Iwabuchi K; Zorina Y; Prinetti A
Neurochem Res; 2023 Jun; 48(6):1783-1797. PubMed ID: 36695984
[TBL] [Abstract][Full Text] [Related]
6. Human IgM antibody rHIgM22 promotes phagocytic clearance of myelin debris by microglia.
Zorina Y; Stricker J; Caggiano AO; Button DC
Sci Rep; 2018 Jun; 8(1):9392. PubMed ID: 29925848
[TBL] [Abstract][Full Text] [Related]
7. The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelination.
Cui C; Wang J; Mullin AP; Caggiano AO; Parry TJ; Colburn RW; Pavlopoulos E
Brain Res; 2018 Sep; 1694():73-86. PubMed ID: 29775564
[TBL] [Abstract][Full Text] [Related]
8. Human Remyelination Promoting Antibody Stimulates Astrocytes Proliferation Through Modulation of the Sphingolipid Rheostat in Primary Rat Mixed Glial Cultures.
Grassi S; Giussani P; Prioni S; Button D; Cao J; Hakimi I; Sarmiere P; Srinivas M; Cabitta L; Sonnino S; Prinetti A
Neurochem Res; 2019 Jun; 44(6):1460-1474. PubMed ID: 30569280
[TBL] [Abstract][Full Text] [Related]
9. PDGF is required for remyelination-promoting IgM stimulation of oligodendrocyte progenitor cell proliferation.
Watzlawik JO; Warrington AE; Rodriguez M
PLoS One; 2013; 8(2):e55149. PubMed ID: 23383310
[TBL] [Abstract][Full Text] [Related]
10. High-affinity binding of remyelinating natural autoantibodies to myelin-mimicking lipid bilayers revealed by nanohole surface plasmon resonance.
Wittenberg NJ; Im H; Xu X; Wootla B; Watzlawik J; Warrington AE; Rodriguez M; Oh SH
Anal Chem; 2012 Jul; 84(14):6031-9. PubMed ID: 22762372
[TBL] [Abstract][Full Text] [Related]
11. Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.
Warrington AE; Rodriguez M
Curr Top Microbiol Immunol; 2008; 318():213-39. PubMed ID: 18219820
[TBL] [Abstract][Full Text] [Related]
12. Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.
Lemus HN; Warrington AE; Denic A; Wootla B; Rodriguez M
Hum Antibodies; 2017; 25(3-4):121-129. PubMed ID: 28269761
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease.
Mitsunaga Y; Ciric B; Van Keulen V; Warrington AE; Paz Soldan M; Bieber AJ; Rodriguez M; Pease LR
FASEB J; 2002 Aug; 16(10):1325-7. PubMed ID: 12154009
[TBL] [Abstract][Full Text] [Related]
14. A comparison of human natural monoclonal antibodies and aptamer conjugates for promotion of CNS remyelination: where are we now and what comes next?
Perwein MK; Smestad JA; Warrington AE; Heider RM; Kaczor MW; Maher LJ; Wootla B; Kunbaz A; Rodriguez M
Expert Opin Biol Ther; 2018 May; 18(5):545-560. PubMed ID: 29460650
[TBL] [Abstract][Full Text] [Related]
15. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virus-induced murine model of MS.
Pirko I; Ciric B; Gamez J; Bieber AJ; Warrington AE; Johnson AJ; Hanson DP; Pease LR; Macura SI; Rodriguez M
FASEB J; 2004 Oct; 18(13):1577-9. PubMed ID: 15319372
[TBL] [Abstract][Full Text] [Related]
16. Targeting of IgMkappa antibodies to oligodendrocytes promotes CNS remyelination.
Asakura K; Miller DJ; Pease LR; Rodriguez M
J Neurosci; 1998 Oct; 18(19):7700-8. PubMed ID: 9742140
[TBL] [Abstract][Full Text] [Related]
17. Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system.
Llufriu-Dabén G; Carrete A; Chierto E; Mailleux J; Camand E; Simon A; Vanmierlo T; Rose C; Allinquant B; Hendriks JJA; Massaad C; Meffre D; Jafarian-Tehrani M
Neurobiol Dis; 2018 Jan; 109(Pt A):11-24. PubMed ID: 28923597
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated remyelination operates through mechanism independent of immunomodulation.
Ciric B; Van Keulen V; Paz Soldan M; Rodriguez M; Pease LR
J Neuroimmunol; 2004 Jan; 146(1-2):153-61. PubMed ID: 14698858
[TBL] [Abstract][Full Text] [Related]
19. The TAM receptor TYRO3 is a critical regulator of myelin thickness in the central nervous system.
Blades F; Aprico A; Akkermann R; Ellis S; Binder MD; Kilpatrick TJ
Glia; 2018 Oct; 66(10):2209-2220. PubMed ID: 30208252
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, placebo-controlled, single-ascending-dose intravenous infusion study of rHIgM22 in subjects with multiple sclerosis immediately following a relapse.
Greenberg BM; Bowen JD; Alvarez E; Rodriguez M; Caggiano AO; Warrington AE; Zhao P; Eisen A
Mult Scler J Exp Transl Clin; 2022; 8(2):20552173221091475. PubMed ID: 35496758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
